Discover 4,544 paid clinical trials in New York State. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
New York State presents a wide array of paid research opportunities for both healthy volunteers and those with specific health concerns. Actively recruiting research institutions in New York City, Buffalo, and Rochester offer access to innovative treatments and exceptional medical care near you.
Filter
1
Filter results
Results: 4,544
Effects of Racial Congruence, "Likes", and Food Images in Social Media Ads on Adolescents' Caloric Intake - Study 3
for
Calorie Consumption
Location: New York NY
Sponsor: NYU Langone Health
Sex: All
Age: 13 - 17
Code: NCT06969651
Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
for
Ulcerative Colitis, Obesity or Overweight
Location: London, New Bedford MA, Providence RI, Lebanon NH,
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
for
Squamous Cell Carcinoma of Head and Neck, Sinus Cancer,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT07063212
Phase2, Recruiting
Early Cochlear Implant Use
for
Cochlear Implant Users
Location: New York NY
Sponsor: NYU Langone Health
Sex: All
Age: 18 - 70+
Code: NCT07114744
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
for
Crohn's Disease, Obesity or Overweight
Location: London, New Bedford MA, Providence RI, Lebanon NH,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70
Code: NCT06937099
Phase3, Recruiting
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
for
Systemic Lupus Erythematosus,
Location: Boston MA, Great Neck NY, New York NY, Rochester NY,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT06570798
Phase2, Recruiting
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
for
Primary Membranous Nephropathy
Location: The Bronx NY, Greenville NC, London, Cleveland OH,
Sponsor: Biogen
Sex: All
Age: 18 - 70+
Code: NCT06962800
Phase3, Recruiting
Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking Adults
for
Cigarette Smoking-Related Carcinoma
Location: Buffalo NY
Sponsor: Roswell Park Cancer Institute
Sex: All
Age: 21 - 55
Code: NCT06816459
Early_phase1, Recruiting
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
for
Plasmablastic Lymphoma,
Location: New York NY, Philadelphia PA, Baltimore MD,
Sponsor: AIDS Malignancy Consortium
Sex: All
Age: 18+
Code: NCT04139304
Early_phase1, Recruiting
FITting Non-invasive Tests in Lynch Syndrome Surveillance
for
Colorectal Cancer
Location: New York NY, Ann Arbor MI, Chicago IL
Sponsor: University of Chicago
Sex: All
Age: 20 - 70+
Code: NCT06898996
Recruiting
A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
for
Chronic Primary Immune Thrombocytopenia (ITP)
Location: Shirley NY, Greenville NC, Los Angeles CA
Sponsor: Kedrion S.p.A.
Sex: All
Age: 18 - 70
Code: NCT07059000
Phase3, Recruiting
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
for
Breast Cancer, Metastatic
Location: New York NY, Washington D.C. DC, Fairfax VA, Miami FL,
Sponsor: ALX Oncology Inc.
Sex: All
Age: 18+
Code: NCT07007559
Phase2, Recruiting
Families Moving Forward (FMF) Connect Pro for Mental Health Providers
for
Fetal Alcohol Spectrum Disorders
Location: Rochester NY
Sponsor: University of Rochester
Sex: All
Age: 18+
Code: NCT05960461
Recruiting
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: All
Age: 1 - 50
Code: NCT01804634
Phase2, Recruiting
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: St. John's, Bangor ME, Scarborough ME, Providence RI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 30
Code: NCT04546399
Phase2, Recruiting
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease